Outpatient Management of Mild-to-Moderate Hypercalcemia

Initial Diagnostic Workup

The American College of Endocrinology recommends measuring serum intact PTH, 25-hydroxyvitamin D, ionized calcium, albumin, phosphorus, magnesium, and creatinine to determine whether hypercalcemia is PTH-dependent or PTH-independent 1, 2
Calculated corrected calcium using the formula: Corrected calcium (mg/dL) = Total calcium (mg/dL) - 0.8 × [Albumin (g/dL) - 4] is recommended, though ionized calcium is preferred if available 2
Elevated or inappropriately normal PTH with hypercalcemia confirms primary hyperparathyroidism, while suppressed PTH indicates a PTH-independent cause 1

Discontinue all calcium supplements, vitamin D supplements, and thiazide diuretics immediately to manage mild-to-moderate hypercalcemia 1, 2
Ensure adequate oral hydration (target 2-3 liters daily) to promote calciuresis and prevent volume depletion 1, 2
Review all medications for potential contributors, including lithium, vitamin A, and calcium-based phosphate binders if the patient has chronic kidney disease 1, 3

Confirm vitamin D status by measuring 25-hydroxyvitamin D to exclude secondary hyperparathyroidism before diagnosing primary hyperparathyroidism 1
Order 24-hour urine calcium or spot urine calcium/creatinine ratio to assess for hypercalciuria and kidney stone risk 2
Obtain renal ultrasound to evaluate for nephrocalcinosis or kidney stones 2
Consider bone density scan to assess for osteoporosis, which influences surgical decision-making 2

Measure PTH-related protein to evaluate for malignancy-associated hypercalcemia, particularly if there is rapid onset, weight loss, or known cancer history 2
Measure 1,25-dihydroxyvitamin D to assess for granulomatous diseases or lymphomas, which cause elevated 1,25-dihydroxyvitamin D despite low 25-hydroxyvitamin D 1, 2
Evaluate for malignancy with age-appropriate cancer screening, chest imaging, and serum/urine protein electrophoresis if multiple myeloma is suspected 2

Refer to emergency department or urgent hospitalization if calcium ≥12 mg/dL with symptoms, calcium ≥14 mg/dL regardless of symptoms, acute kidney injury, ECG changes, or mental status changes 1, 2

Do not order parathyroid imaging before confirming biochemical diagnosis of primary hyperparathyroidism—imaging is for surgical planning, not diagnosis 1
Do not assume hypercalcemia is benign even if asymptomatic—untreated hypercalcemia can lead to nephrocalcinosis, kidney stones, osteoporosis, and cardiac arrhythmias 2, 4
Do not start bisphosphonates in the outpatient setting for mild hypercalcemia—these are reserved for moderate-to-severe symptomatic hypercalcemia or malignancy-associated hypercalcemia 2, 3

Recheck calcium, creatinine, and PTH within 2-4 weeks after initial diagnosis to confirm persistent hypercalcemia and guide further management 1, 2
Monitor serum calcium every 3-6 months, creatinine every 6-12 months, and bone density annually for patients managed conservatively 1